Simon Briggs

Director - Advanced Analytics Orchard Therapeutics

Seminars

Thursday 7th May 2026
Supporting Analytical Tech Transfer Under Real-World Constraints to Maintain Method Identity, Reduce Drift & Avoid Rebuilding Assays Mid-Development
11:15 am
  • Explore how analytical developers can protect method intent when transferring into a platform environment
  • Diagnose performance changes post-transfer and deciding between retraining, re-optimisation, or full method redevelopment
  • How to interpret shifts in potency signal, vector titre, or impurity profiles across sites
Simon Briggs - Director of Advanced Analytics, Orchard Therapeutics - Expert Speaker at the 7th Gene Therapy Analytical Development Europe 2026